Biolife Solutions (BLFS) Cash from Financing Activities (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly Cash from Financing Activities of -$7.9 million for Q1 2026, down 163.87% year-over-year from $12.4 million in Q1 2025, and down 216.31% quarter-over-quarter from -$2.5 million in Q4 2025.
Biolife Solutions (BLFS) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Cash from Financing Activities for 17 consecutive years, with -$7.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 163.87% year-over-year to -$7.9 million; the TTM figure through Mar 2026 stood at -$15.8 million (down 79.38% YoY), while the FY2025 annual figure was -$10.9 million, down 61.05% from the prior year.
- Cash from Financing Activities slipped to -$7.9 million in Q1 2026 per BLFS's latest filing, from -$2.5 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $17.4 million in Q3 2022 and bottomed at -$7.9 million in Q1 2026.
- Historically, Cash from Financing Activities has averaged $76764.7 across 5 years, with a median of -$704000.0 in 2024.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities jumped 1745.65% — and 2025, when it plunged 308.81%.
- Biolife Solutions' Cash from Financing Activities stood at -$625000.0 in 2022, then surged by 1674.56% to $9.8 million in 2023, then plunged by 141.52% to -$4.1 million in 2024, then surged by 38.91% to -$2.5 million in 2025, then tumbled by 216.31% to -$7.9 million in 2026.
- Business Quant data shows BLFS's Cash from Financing Activities at -$7.9 million in Q1 2026, -$2.5 million in Q4 2025, and -$2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Biolife Solutions | 1.82 Bn | 1.73 Bn | 18.29 Mn | -3.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.59 Mn |
| Jun 30, 2026 | -3.59 Mn |
| Mar 31, 2026 | -7.90 Mn |
| Mar 31, 2026 | -7.90 Mn |
| Dec 31, 2025 | -2.50 Mn |
| Dec 31, 2025 | -2.50 Mn |
| Sep 30, 2025 | -2.56 Mn |
| Sep 30, 2025 | -2.56 Mn |
| Jun 30, 2025 | -2.88 Mn |
| Jun 30, 2025 | -2.88 Mn |
| Mar 31, 2025 | -2.99 Mn |
| Mar 31, 2025 | -2.99 Mn |
| Dec 31, 2024 | -4.09 Mn |
| Dec 31, 2024 | -4.09 Mn |
| Sep 30, 2024 | -1.04 Mn |
| Sep 30, 2024 | -1.04 Mn |
| Jun 30, 2024 | -704,000.00 |
| Jun 30, 2024 | -704,000.00 |
| Mar 31, 2024 | -952,000.00 |
| Mar 31, 2024 | -952,000.00 |